journal
https://read.qxmd.com/read/39361545/honoring-a-legacy-vigyan-ratna-prof-g-padmanaban
#1
EDITORIAL
Varadharajan Sundaramurthy, Jayanta Haldar
No abstract text is available yet for this article.
October 3, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39360674/2-aryl-benzoimidazoles-as-type-ii-nadh-dehydrogenase-inhibitors-of-mycobacterium-tuberculosis
#2
JOURNAL ARTICLE
Pallavi Saha, Shashikanta Sau, Nitin Pal Kalia, Deepak K Sharma
The nonproton pumping type II NADH dehydrogenase in Mycobacterium tuberculosis is essential for meeting the energy needs in terms of ATP under normal aerobic and stressful hypoxic environmental states. Type II NADH dehydrogenase conduits electrons into the electron transport chain in Mycobacterium tuberculosis , which results in ATP synthesis. Therefore, the inhibition of NDH-2 ensures the abolishment of the entire ATP synthesis machinery. Also, type II NADH dehydrogenase is absent in the mammalian genome, thus making it a potential target for antituberculosis drug discovery...
October 3, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39360613/-mycobacterium-tuberculosis-suppresses-inflammatory-responses-in-host-through-its-cholesterol-metabolites
#3
JOURNAL ARTICLE
Jing Wu, Yong Zhang, Wenqi Li, Hao Tang, Ying Zhou, Di You, Xiaohe Chu, Hanbing Li, Jinsai Shang, Nan Qi, Bang-Ce Ye
Cholesterol is a key carbon source for Mycobacterium tuberculosis (Mtb) survival and persistence within macrophages. However, little is known about the role of cholesterol metabolism by Mtb in host-Mtb interplay. Here, we report the immune suppression mediated by Mtb's cholesterol metabolites. Conducting the cholesterol metabolic profiling and loss-of-function experiments, we show that the cholesterol oxidation products catalyzed by a thiolase FadA5 from Mtb H37Ra, 4-androstenedione (AD), and its derivant 1,4-androstenedione (ADD) inhibit the expression of pro-inflammatory cytokines and thus promote bacterial survival in bone marrow-derived macrophages (BMDMs)...
October 3, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39357850/high-affinity-inhibitors-of-the-macrophage-infectivity-potentiator-protein-from-trypanosoma-cruzi-burkholderia-pseudomallei-and-legionella-pneumophila-%C3%A2-a-comparison
#4
JOURNAL ARTICLE
Theresa Lohr, Carina Herbst, Nicole M Bzdyl, Christopher Jenkins, Nicolas J Scheuplein, Wisely Oki Sugiarto, Jacob J Whittaker, Albert Guskov, Isobel Norville, Ute A Hellmich, Felix Hausch, Mitali Sarkar-Tyson, Christoph Sotriffer, Ulrike Holzgrabe
Since Chagas disease, melioidosis, and Legionnaires' disease are all potentially life-threatening infections, there is an urgent need for new treatment strategies. All causative agents, Trypanosoma cruzi , Burkholderia pseudomallei , and Legionella pneumophila , express a virulence factor, the macrophage infectivity potentiator (MIP) protein, emerging as a promising new therapeutic target. Inhibition of MIP proteins having a peptidyl-prolyl isomerase activity leads to reduced viability, proliferation, and cell invasion...
October 2, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39356820/tolfenpyrad-derivatives-exhibit-potent-francisella-specific-antibacterial-activity-without-toxicity-to-mammalian-cells-in-vitro
#5
JOURNAL ARTICLE
Nimra Khalid, Nicole Adams, Federico Cunha, Aya C Taki, Thuy G Le, Jonathan B Baell, Henry S Heine, Robin B Gasser, Aria Eshraghi
Tularemia is a deadly disease caused by Francisella tularensis , an emerging intracellular bacterial pathogen that can be disseminated rapidly through aerosols and vector-borne transmission. Recent surveillance data demonstrate an increasing incidence in several countries. Although clinical isolates of Francisella strains are sensitive to currently used antibiotics, engineered or horizontal acquisition of antibiotic resistance is a constant threat to public health. Therefore, the identification of antibiotics that target previously undrugged pathways is required to safeguard human health...
October 2, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39352879/repositioning-brusatol-as-a-transmission-blocker-of-malaria-parasites
#6
JOURNAL ARTICLE
Amelia Cox, Neelima Krishnankutty, Steven Shave, Virginia M Howick, Manfred Auer, James J La Clair, Nisha Philip
Currently, primaquine is the only malaria transmission-blocking drug recommended by the WHO. Recent efforts have highlighted the importance of discovering new agents that regulate malarial transmission, with particular interest in agents that can be administered in a single low dose, ideally with a discrete and Plasmodium -selective mechanism of action. Here, our team demonstrates an approach to identify malaria transmission-blocking agents through a combination of in vitro screening and in vivo analyses. Using a panel of natural products, our approach identified potent transmission blockers, as illustrated by the discovery of the transmission-blocking efficacy of brusatol...
October 1, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39331790/8-hydroxyquinoline-series-exerts-bactericidal-activity-against-mycobacterium-tuberculosis-via-copper-mediated-toxicity
#7
JOURNAL ARTICLE
Amala Bhagwat, Arielle Butts, Eric Greve, Yan Cheung, Eduard Melief, James Gomez, Deborah T Hung, Tanya Parish
New drugs and mechanisms of action targeting Mycobacterium tuberculosis are urgently needed to solve the global pandemic of tuberculosis. We previously demonstrated that the 8-hydroxyquinoline series has rapid bactericidal activity against M. tuberculosis . In this work, we determined that the activity of the 8HQ series is potentiated by copper ions and that the activity is dependent on copper since activity was reduced when copper was depleted from the medium. We determined that exposure to 8HQs led to an increase in intracellular copper...
September 27, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39327729/3-benzylmenadiones-and-their-heteroaromatic-analogues-target-the-apicoplast-of-apicomplexa-parasites-synthesis-and-bioimaging-studies
#8
JOURNAL ARTICLE
Baptiste Dupouy, Maxime Donzel, Matthieu Roignant, Sarah Charital, Rodrigue Keumoe, Yoshiki Yamaryo-Botté, Alexander Feckler, Mirco Bundschuh, Yann Bordat, Matthias Rottmann, Pascal Mäser, Cyrille Y Botté, Stéphanie A Blandin, Sébastien Besteiro, Elisabeth Davioud-Charvet
The apicoplast is an essential organelle for the viability of apicomplexan parasites Plasmodium falciparum or Toxoplasma gondii , which has been proposed as a suitable drug target for the development of new antiplasmodial drug-candidates. Plasmodione, an antimalarial redox-active lead drug is active at low nM concentrations on several blood stages of Plasmodium such as early rings and gametocytes. Nevertheless, its precise biological targets remain unknown. Here, we described the synthesis and the evaluation of new heteroaromatic analogues of plasmodione, active on asexual blood P...
September 26, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39315541/role-of-dna-double-strand-break-formation-in-gyrase-inhibitor-mediated-killing-of-nonreplicating-persistent-mycobacterium-tuberculosis-in-caseum
#9
JOURNAL ARTICLE
Priyanka Ashwath, Paulina Osiecki, Danielle Weiner, Laura E Via, Jansy P Sarathy
Tuberculosis is the leading cause of mortality by infectious agents worldwide. The necrotic debris, known as caseum, which accumulates in the center of pulmonary lesions and cavities is home to nonreplicating drug-tolerant Mycobacterium tuberculosis that presents a significant hurdle to achieving a fast and durable cure. Fluoroquinolones such as moxifloxacin are highly effective at killing this nonreplicating persistent bacterial population and boosting TB lesion sterilization. Fluoroquinolones target bacterial DNA gyrase, which catalyzes the negative supercoiling of DNA and relaxes supercoils ahead of replication forks...
September 24, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39313410/activation-pathways-of-murine-macrophages-by-lipophosphoglycan-from-strains-of-leishmania-major-fv1-and-lv39
#10
JOURNAL ARTICLE
Vanessa Mançur Santos, Astrid Madeleine Calero Goicochea, Antônio José Soares Neto, Flávio Henrique Jesus Santos, Jéssica Lobo da Silva, Théo Araújo-Santos, Leonardo Paiva Farias, Claudia Ida Brodskyn, Valéria M Borges, Rodrigo Pedro Soares, Jonilson Berlink Lima
Lipophosphoglycan (LPG) is an important Leishmania virulence factor. It is the most abundant surface glycoconjugate in promastigotes, playing an important role in the interaction with phagocytic cells. While LPG is known to modulate the macrophage immune response during infection, the activation mechanisms triggered by this glycoconjugate have not been fully elucidated. This work investigated the role that LPGs purified from two strains of Leishmania major (FV1 and LV39) play in macrophage activation, considering the differences in their biochemical structures...
September 23, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39306863/control-of-hepatitis-b-virus-with-imdusiran-a-small-interfering-rna-therapeutic
#11
JOURNAL ARTICLE
Emily P Thi, Xin Ye, Nicholas M Snead, Amy C H Lee, Holly M Micolochick Steuer, Andrzej Ardzinski, Ingrid E Graves, Christine Espiritu, Andrea Cuconati, Cory Abbott, Agnes Jarosz, Xiaowei Teng, Bhavna Paratala, Kevin McClintock, Troy Harasym, Rene Rijnbrand, Angela M Lam, Michael J Sofia
Chronic hepatitis B is a global health concern with a high risk of end-stage liver disease. Current standard-of-care agents have low cure rates, and new therapies are needed. Small interfering RNAs (siRNAs) that target viral RNAs fulfill a gap not addressed by standard-of-care agents and may contribute to a functional cure. Here, we describe the preclinical characterization of imdusiran (AB-729), a novel, pan-genotypic siRNA therapeutic that effectively reduces HBsAg, viral antigens, and viral replication in chronic hepatitis B patients and is currently in Phase 2 clinical studies...
September 22, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39303151/lung-damage-induced-by-plasmodium-berghei-anka-in-murine-model-of-malarial-infection-is-mitigated-by-dietary-supplementation-with-dha-rich-omega-3
#12
JOURNAL ARTICLE
Carolina David-Vieira, Barbara Albuquerque Carpinter, Jéssica Correia Bezerra-Bellei, Letícia Ferreira Machado, Felipe Oliveira Raimundo, Cinthia Magalhães Rodolphi, Daniela Chaves Renhe, Isabella Rodrigues Nogueira Guedes, Fernanda Mikaela Moreira Gonçalves, Ludmila Ponce Monken Custódio Pereira, Marcos Vinicius Rangel Ferreira, Haroldo Lobo Dos Santos Nascimento, Adolfo Firmino Neto, Flávia Lima Ribeiro Gomes, Vinicius Novaes Rocha, Juciane Maria de Andrade Castro, Kézia Katiani Gorza Scopel
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe complications that can occur in infections caused by any Plasmodium species. Due to the high lethality rate and the lack of specific treatment for ALI/ARDS, studies aimed at understanding and searching for treatment strategies for such complications have been fundamental. Here, we investigated the protective role of dietary supplementation with DHA-rich fish oil against lung damage induced by Plasmodium berghei ANKA in a murine model...
September 20, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39303064/native-mass-spectrometry-reveals-binding-interactions-of-sars-cov-2-plpro-with-inhibitors-and-cellular-targets
#13
JOURNAL ARTICLE
Virginia K James, Rianna N Godula, Jessica M Perez, Josh T Beckham, Jamie P Butalewicz, Sarah N Sipe, Jon M Huibregtse, Jennifer S Brodbelt
Here we used native mass spectrometry (native MS) to probe a SARS-CoV protease, PLpro, which plays critical roles in coronavirus disease by affecting viral protein production and antagonizing host antiviral responses. Ultraviolet photodissociation (UVPD) and variable temperature electrospray ionization (vT ESI) were used to localize binding sites of PLpro inhibitors and revealed the stabilizing effects of inhibitors on protein tertiary structure. We compared PLpro from SARS-CoV-1 and SARS-CoV-2 in terms of inhibitor and ISG15 interactions to discern possible differences in protease function...
September 20, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39291389/enzyme-dynamics-determine-the-potency-and-selectivity-of-inhibitors-targeting-disease-transmitting-mosquitoes
#14
JOURNAL ARTICLE
Rashmi Kumari, Cecilia Lindgren, Rajendra Kumar, Nina Forsgren, C David Andersson, Fredrik Ekström, Anna Linusson
Vector control of mosquitoes with insecticides is an important tool for preventing the spread of mosquito-borne diseases including malaria, dengue, chikungunya, and Zika. Development of active ingredients for insecticides are urgently needed because existing agents exhibit off-target toxicity and are subject to increasing resistance. We therefore seek to develop noncovalent inhibitors of the validated insecticidal target acetylcholinesterase 1 (AChE1) from mosquitoes. Here we use molecular dynamics simulations to identify structural properties essential for the potency of reversible inhibitors targeting AChE1 from Anopheles gambiae ( Ag AChE1), the malaria-transmitting mosquito, and for selectivity relative to the vertebrate Mus musculus AChE ( m AChE)...
September 18, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39283729/licochalcone-a-ameliorates-aspergillus-fumigatus-keratitis-by-reducing-fungal-load-and-activating-the-nrf2-ho-1-signaling-pathway
#15
JOURNAL ARTICLE
Yiran Tian, Junjie Luan, Qian Wang, Cui Li, Xudong Peng, Nan Jiang, Guiqiu Zhao, Jing Lin
Fungal keratitis (FK) is a blinding corneal infectious disease. The prognosis is frequently unfavorable due to fungal invasion and an excessive host inflammatory response. Licochalcone A (Lico A) exhibits a broad spectrum of pharmacological activities, encompassing antifungal, anti-inflammatory, antioxidation, and antitumor properties. However, the role of Lico A has not yet been studied in FK. In this study, we discovered that Lico A could disrupt Aspergillus fumigatus ( A. fumigatus ) biofilms, inhibit fungal growth and adhesion to host cells, induce alterations of hyphal morphology, and impair the cell membrane and cell wall integrity and mitochondrial structure of A...
September 16, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39268963/identification-of-chemical-scaffolds-that-inhibit-the-mycobacterium-tuberculosis-respiratory-complex-succinate-dehydrogenase
#16
JOURNAL ARTICLE
Cara Adolph, Kiel Hards, Zoe C Williams, Chen-Yi Cheung, Laura M Keighley, William J Jowsey, Matson Kyte, Daniel Ken Inaoka, Kiyoshi Kita, Jared S Mackenzie, Adrie J C Steyn, Zhengqiu Li, Ming Yan, Guo-Bao Tian, Tianyu Zhang, Xiaobo Ding, Daniel P Furkert, Margaret A Brimble, Anthony J R Hickey, Matthew B McNeil, Gregory M Cook
Drug-resistant Mycobacterium tuberculosis is a significant cause of infectious disease morbidity and mortality for which new antimicrobials are urgently needed. Inhibitors of mycobacterial respiratory energy metabolism have emerged as promising next-generation antimicrobials, but a number of targets remain unexplored. Succinate dehydrogenase (SDH), a focal point in mycobacterial central carbon metabolism and respiratory energy production, is required for growth and survival in M. tuberculosis under a number of conditions, highlighting the potential of inhibitors targeting mycobacterial SDH enzymes...
September 13, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39259670/fatty-acid-uptake-in-klebsiella-pneumoniae-and-the-landscape-of-its-infectious-niches
#17
JOURNAL ARTICLE
Ella Haracic, Jack K Waters, To Nguyen Thi Nguyen, Xenia Kostoulias, Brynley J Davies, Long Yu, Anton Y Peleg, Vincent Bulone, Francesca L Short, Bart A Eijkelkamp
Klebsiella pneumoniae is consistently ranked among the most problematic multidrug-resistant bacterial pathogens in healthcare systems. Developing novel treatments requires a better understanding of its interaction with the host environment. Although bacteria can synthesize fatty acids, emerging findings suggest a potential preference for their acquisition from the host. Fatty acid profiling of mice revealed a dramatic increase in the level of hepatic lipids during K . pneumoniae infection. The K . pneumoniae fatty acid composition and uptake capabilities were found to be largely clonally conserved...
September 11, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39255460/crystal-structures-of-the-acinetobacter-baumannii-macrolide-phosphotransferase-e
#18
JOURNAL ARTICLE
Qianqian Qi, Linghan Kuang, Jing Liao, Xiang Wang, Yanxia Zhou, Li Guo, Yongmei Jiang
Acinetobacter baumannii ( A. baumannii ) challenges clinical infection treatment due to its resistance to various antibiotics. Multiple resistance genes in the core genome or mobile elements contribute to multidrug resistance in A. baumannii . Macrolide phosphotransferase gene mphE has been identified in A. baumannii , which is particularly relevant to macrolide antibiotics. Here, we determined the structure of MphE protein in three states: the apo state, the complex state with erythromycin and guanosine triphosphate (GTP), and the complex state with azithromycin and guanosine...
September 10, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39255073/the-road-ahead-advancing-antifungal-vaccines-and-addressing-fungal-infections-in-the-post-covid-world
#19
REVIEW
Xiaolong Gong, Mohmmad Younus Wani, Abdullah Saad Al-Bogami, Aijaz Ahmad, Keven Robinson, Amber Khan
In impoverished nations, the COVID-19 pandemic has led to a widespread occurrence of deadly fungal diseases like mucormycosis. The limited availability of effective antifungal treatments and the emergence of drug-resistant fungal strains further exacerbate the situation. Factors such as systemic steroid use, intravenous drug misuse, and overutilization of broad-spectrum antimicrobials contribute to the prevalence of hospital-acquired infections caused by drug-resistant fungi. Fungal infections exploit compromised immune status and employ intricate mechanisms to evade immune surveillance...
September 10, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/39236267/mycobacterium-laci-type-transcription-regulator-rv3575c-affects-host-innate-immunity-by-regulating-bacterial-mce4-operon-mediated-cholesterol-transport
#20
JOURNAL ARTICLE
Junfeng Zhen, Yuerigu Abuliken, Yaru Yan, Chaoyun Gao, Zhiyong Jiang, Tingting Huang, Thi Thu Thuy Le, Liying Xiang, Peibo Li, Jianping Xie
Mycobacterium tuberculosis has evolved a highly specialized system to snatch essential nutrients from its host, among which host-derived cholesterol has been established as one main carbon source for M. tuberculosis to survive within granulomas. The uptake, catabolism, and utilization of cholesterol are important for M. tuberculosis to sustain within the host largely via remodeling of the bacterial cell walls. However, the regulatory mechanism of cholesterol uptake and its impact on bacterium fate within infected hosts remain elusive...
September 5, 2024: ACS Infectious Diseases
journal
journal
50106
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.